Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q2 2025 Earnings

Apr 24Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
0.08
0.18
0.28
0.38

Details

Expected EPS
0.096190010784
Actual EPS
0.11403860167391999
Surprise EPS
0.02
Surprise Percent
+18.56%

Description

⁨Shenzhen Hepalink Pharmaceutical Group.⁩ (⁦9989.HK⁩) has reported earnings of ⁦0.11403860167391999⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts